Brokerages Set electroCore, Inc. (NASDAQ:ECOR) PT at $22.00

electroCore, Inc. (NASDAQ:ECOR) has been assigned an average rating of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $22.00.

ECOR has been the subject of a number of analyst reports. HC Wainwright dropped their price target on shares of electroCore from $25.00 to $18.00 and set a “buy” rating for the company in a research report on Monday, January 26th. Brookline Capital Acquisition raised electroCore to a “strong-buy” rating in a report on Tuesday, February 3rd. Zacks Research downgraded electroCore from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 28th. Brookline Cap M upgraded shares of electroCore to a “strong-buy” rating in a research report on Tuesday, February 3rd. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research note on Monday, December 29th.

electroCore News Summary

Here are the key news stories impacting electroCore this week:

• Positive Sentiment: Brookline Capital Management upgraded ECOR to a “Strong-Buy” and published new estimates that point toward improving profitability — forecasting FY2026 EPS of ($0.53) and a near-breakeven Q4 2026 EPS of ($0.01), which investors may view as a catalyst for the stock. Zacks Upgrade
• Neutral Sentiment: Brookline released a detailed quarter-by-quarter EPS schedule (Q4 2025: ($0.39); Q1 2026: ($0.33); Q2 2026: ($0.12); Q3 2026: ($0.08); Q4 2026: ($0.01)) giving investors a roadmap for when improvement is expected, but these are analyst projections rather than company guidance. MarketBeat Estimates
• Negative Sentiment: Despite the upgrade, Brookline still models a sizable loss for FY2025 (forecast: ($1.70) EPS), which is worse than the current consensus full-year estimate of ($1.49) — a reminder that near-term profitability and cash flow remain risk factors. MarketBeat Estimates

electroCore Trading Up 7.5%

ECOR opened at $5.45 on Thursday. The stock has a market cap of $43.60 million, a PE ratio of -3.19 and a beta of 0.48. The stock’s fifty day simple moving average is $5.59 and its 200 day simple moving average is $5.42. electroCore has a 1-year low of $4.16 and a 1-year high of $19.49.

electroCore (NASDAQ:ECOR) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($0.07). The company had revenue of $8.69 million during the quarter, compared to the consensus estimate of $7.84 million. electroCore had a negative net margin of 47.46% and a negative return on equity of 447.87%. Equities analysts forecast that electroCore will post -1.49 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. NewEdge Advisors LLC raised its position in shares of electroCore by 857.9% in the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock worth $1,083,000 after acquiring an additional 145,047 shares in the last quarter. Tejara Capital Ltd bought a new stake in shares of electroCore in the 4th quarter valued at $450,000. International Assets Investment Management LLC lifted its position in shares of electroCore by 65.7% during the 2nd quarter. International Assets Investment Management LLC now owns 77,020 shares of the company’s stock valued at $407,000 after acquiring an additional 30,550 shares during the period. Cubist Systematic Strategies LLC acquired a new position in shares of electroCore during the 1st quarter valued at $153,000. Finally, Jane Street Group LLC boosted its stake in electroCore by 114.4% during the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after acquiring an additional 19,599 shares in the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

About electroCore

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.